Disappointing Results From Latest Trial of Prospective Alzheimer Tx - Monthly Prescribing Reference

Submitted by Anonymous (not verified) on Wed, 01/10/2018 - 15:08

Los Angeles TimesDisappointing Results From Latest Trial of Prospective Alzheimer TxMonthly Prescribing ReferenceHealthDay News — The use of idalopirdine does not improve cognition versus placebo over 24 weeks of treatment for patients with mild-to-moderate Alzheimer's disease (AD), according to research published in the January 9 issue of the Journal of the ...Health Highlights: Jan. 10, 2018HealthDayall 10 news articles »